Marker Therapeutics, Inc. — Director's Dealing 2004

Feb 17, 2004

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: GENEMAX CORP (GMXX)
CIK: 0001094038
Period of Report: 2003-12-31

Reporting Person: GENEMAX CORP (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2003-12-31	Common Stock $0.001 par value	A	0.00	$0.00	Acquired	0.00	Direct
2003-12-31	Common Stock $0.001 par value	A	0.00	$0.00	Disposed	27500	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2003-08-05	Stock Options	$1.00	J	150000	Disposed		Common Stock (150000)	Direct

Footnotes

F1: Held of record by Alan Lindsay and Associated Ltd., over which Mr. Lindsay has solo voting and disposition rights.

F2: Pursuant to Mr. Linday's resignation from the Board of Directors effective May 7, 2003, the 150,000 stock options previously granted to Mr. Lindsay were forfeited on August 5, 2003 in accordance with the terms and provisions of the Stock Option Plan.